S1416

Please Note: This trial is no longer enrolling new participants

PHASE II RANDOMIZED PLACEBO-CONTROLLED TRIAL OF CISPLATIN WITH OR WITHOUT ABT-888 (VELIPARIB) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND/OR BRCA MUTATION-ASSOCIATED BREAST CANCER

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
Rodler E;Sharma P;Barlow WE;Gralow JR;Puhalla SL;Anders CK;Goldstein L;Tripathy D;Brown-Glaberman UA;Huynh TT;Szyarto CS;Godwin AK;Pathak HB;Swisher EM;Radke MR;Timms KM;Lew DL;Miao J;Pusztai L;Hayes DF;Hortobagyi GN;